- Filed
- Apr 30, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 27, 2026 | 60.05M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 60.4M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 61M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $200M |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $450M |
| Dividends Paid | Q1 2026 · Mar 31, 2026 | $51M |
| Dividends Paid | Q1 2026 · Mar 31, 2025 | $49M |
| Capex | Q1 2026 · Mar 31, 2026 | $186M |
| Capex | Q1 2026 · Mar 31, 2025 | $233M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $227M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $218M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $5.29B |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $5.29B |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $273M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $67M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $11.3B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $10.03B |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $1.03B |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $895M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $9.2B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $8.68B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $2.36B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $3.19B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $20.5B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $18.71B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $25.06 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $1.90 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $25.11 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $1.91 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $133M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $125M |
| Net Income | Q1 2026 · Mar 31, 2026 | $1.51B |
| Net Income | Q1 2026 · Mar 31, 2025 | $116M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $162M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | $179M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $310M |
| Gross Profit restated | Q1 2026 · Mar 31, 2025 | $315M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $1.05B |
| Cost Of Revenue restated | Q1 2026 · Mar 31, 2025 | $847M |
| Revenue | Q1 2026 · Mar 31, 2026 | $1.36B |
| Revenue restated | Q1 2026 · Mar 31, 2025 | $1.16B |